natgillin/translations-raw huggingface dataset:
By way of derogation from paragraph 1, for each authorised plant protection product containing emamectin as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 30 April 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
Odstupajući od stavka 1., države članice najkasnije do 30. travnja 2014. moraju ponovno ocijeniti svako odobreno sredstvo za zaštitu bilja koje sadržava emamektin kao jedinu aktivnu tvar ili kao jednu od nekoliko aktivnih tvari koje su navedene u Prilogu Provedbenoj uredbi (EU) br. 540/2011, u skladu s jedinstvenim načelima iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009, na temelju dokumentacije koja udovoljava zahtjevima iz Priloga III. Direktivi 91/414/EEZ i uzimajući u obzir stupac s posebnim odredbama iz Priloga I. ovoj Uredbi.
in the case of a product containing emamectin as the only active substance, where necessary, amend or withdraw the authorisation by 31 October 2015 at the latest; or
u slučaju da sredstvo sadržava emamektin kao jedinu aktivnu tvar, prema potrebi izmijeniti ili povući odobrenje najkasnije do 31. listopada 2015.; ili
in the case of a product containing emamectin as one of several active substances, where necessary, amend or withdraw the authorisation by 31 October 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
u slučaju da sredstvo sadržava emamektin kao jednu od nekoliko aktivnih tvari, prema potrebi izmijeniti ili povući odobrenje do 31. listopada 2015. ili do datuma utvrđenog za izmjenu ili povlačenje u odgovarajućem aktu ili aktima kojima su dotična tvar ili tvari uvrštene u Prilog I. Direktivi 91/414/EEZ ili kojima su dotična tvar ili tvari odobrene, ovisno o tome što je kasnije.
It shall apply from 1 May 2014.
Primjenjuje se od 1. svibnja 2014.
OJ L 274, 18.10.2007, p. 15.
SL L 274, 18.10.2007., str. 15.
Common name, identification numbers
Uobičajeni naziv, identifikacijski brojevi
IUPAC name
Naziv prema IUPAC-u
Emamectin
Emamektin
CAS No
CAS br.
emamectin: 119791-41-2
emamektin: 119791-41-2
(formerly 137335-79-6) and 123997-28-4
(ranije 137335-79-6) i 123997-28-4
emamectin benzoate: 155569-91-8
emamektin benzoat: 155569-91-8
(formerly 137512-74-4 and 179607-18-2)
(ranije 137512-74-4 i 179607-18-2)
emamectin B1a benzoate: 138511-97-4
emamektin B1a benzoat: 138511-97-4
emamectin B1b benzoate: 138511-98-5
emamektin B1b benzoat: 138511-98-5
CIPAC No
CIPAC br.
emamectin: 791
emamektin: 791
emamectin benzoate: 791.412
emamektin benzoat: 791.412
Emamectin B1a:
Emamektin B1a:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sek-butil]-21,24-dihidroksi-5′,11,13,22-tetrametil-2-okso-(3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22- tetraen)-6-spiro-2′-(5′,6′-dihidro-2′H-piran)-12-il 2,6-dideoksi-3-O-metil-4-O-(2,4,6-trideoksi-3-O-metil-4-metilamino-α-L-likso-heksapiranosil)-α-L-arabino-heksapiranosid
Emamectin B1b:
Emamektin B1b:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihidroksi-6′-izopropil-5′,11,13,22-tetrametil-2-okso-(3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihidro-2′H-piran)-12-il 2,6-dideoksi-3-O-metil-4-O-(2,4,6-trideoksi-3-O-metil-4-metilamino-α-L-likso-heksapiranosil)-α-L-arabino-heksapiranosid
Emamectin B1a benzoate:
Emamektin B1a benzoat:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside benzoate
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sek-butil]-21,24-dihidroksi-5′,11,13,22-tetrametil-2-okso-(3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihidro-2′H-piran)-12-il 2,6-dideoksi-3-O-metil-4-O-(2,4,6-trideoksi-3-O-metil-4-metilamino-α-L-likso-heksapiranosil)-α-L-arabino-heksapiranosid benzoat
Emamectin B1b benzoate:
Emamektin B1b benzoat:
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-3-O-methyl-4-O-(2,4,6-trideoxy-3-O-methyl-4-methylamino-α-L-lyxo-hexapyranosyl)-α-L-arabino-hexapyranoside benzoate
,14E,16E)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihidroksi-6′-izopropil-5′,11,13,22-tetrametil-2-okso-(3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22-tetraen)-6-spiro-2′-(5′,6′-dihidro-2′H-piran)-12-il 2,6-dideoksi-3-O-metil-4-O-(2,4,6-trideoksi-3-O-metil-4-metilamino-α-L-likso-heksapiranosil)-α-L-arabino-heksapiranosid benzoat
as emamectin benzoate anhydrous
kao bezvodni emamektin benzoat
(a mixture of min. 920 g/kg emamectin B1a benzoate and max. 50 g/kg emamectin B1b benzoate)
(smjesa najmanje 920 g/kg emamektin B1a benzoata i najviše 50 g/kg emamektin B1b benzoata)
1 May 2014
1. svibnja 2014.
30 April 2024
30. travnja 2024.
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on emamectin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
Za provedbu jedinstvenih načela iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009 u obzir se moraju uzeti zaključci izvješća o ponovnoj ocjeni za emamektin, a posebno njegovi dodaci I. i II. u konačnoj inačici Stalnog odbora za prehrambeni lanac i zdravlje životinja od 16. srpnja 2013.
the risk to non-target invertebrates;
na rizik za beskralježnjake koji ne pripadaju ciljnoj skupini,
the protection of workers and operators.
na zaštitu radnika i primjenitelja.
The applicant shall submit confirmatory information as regards the risk of enantio-selective metabolisation or degradation.
Podnositelj zahtjeva mora dostaviti potvrdne informacije o riziku enantio-selektivnog metabolizma ili razgradnje.
The applicant shall submit to the Commission, Member States and the Authority the relevant information two years after adoption of the pertinent guidance document on evaluation of isomer mixtures.
Podnositelj zahtjeva mora dostaviti odgovarajuće informacije Komisiji, državama članicama i Agenciji dvije godine nakon donošenja odgovarajućeg dokumenta kojim se pružaju smjernice za smjese izomera.
The applicant shall submit to the Commission, Member States and the Authority the relevant information two years after adoption of the pertinent guidance document on evaluation of isomer mixtures.’
Podnositelj zahtjeva mora dostaviti odgovarajuće informacije Komisiji, državama članicama i Agenciji dvije godine nakon donošenja odgovarajućeg dokumenta kojim se pružaju smjernice za smjese izomera.”
For emamectin the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2007/669/EC [3].
Odlukom Komisije 2007/669/EZ [3] potvrđeno je da emamektin ispunjava uvjete iz članka 80. stavka 1. točke (a) Uredbe (EZ) br. 1107/2009.
Without prejudice to the obligations provided for in Regulation (EC) No 1107/2009 as a consequence of approval, taking into account the specific situation created by the transition from Directive 91/414/EEC to Regulation (EC) No 1107/2009, the following should, however, apply. Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing emamectin.
Ne dovodeći u pitanje obveze predviđene Uredbom (EZ) br. 1107/2009 koje proizlaze iz odobrenja i uzimajući u obzir posebnu situaciju nastalu prelaskom s Direktive 91/414/EEZ na Uredbu (EZ) br. 1107/2009, trebalo bi se međutim primjenjivati sljedeće: državama članicama bi nakon odobrenja trebalo omogućiti šestomjesečno razdoblje za ponovnu ocjenu odobrenja sredstava za zaštitu bilja koja sadržavaju emamektin.
Commission Implementing Regulation (EU) No 829/2013
Provedbena uredba Komisije (EU) br. 829/2013
approving the active substance Pseudomonas sp. strain DSMZ 13134, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobravanju aktivne tvari Pseudomonas sp. soj DSMZ 13134, u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja i o izmjeni Priloga Provedbenoj uredbi Komisije(EU) br. 540/2011
In accordance with Article 6(2) of Directive 91/414/EEC the Netherlands received on 28 August 2007 an application from Sourcon-Padena GmbH & Co. KG for the inclusion of the active substance Pseudomonas sp. strain DSMZ 13134 in Annex I to Directive 91/414/EEC.
U skladu s člankom 6. stavkom 2. Direktive 91/414/EEC Nizozemska je 28. kolovoza 2007. od trgovačkog društva Sourcon-Padena GmbH & Co. KG primila zahtjev za uvrštenje aktivne tvari Pseudomonas sp. soj DSMZ 13134 u Prilog I. Direktivi 91/414/EEZ.
Decision 2008/599/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Odlukom 2008/599/EZ potvrđeno je da je dokumentacija bila „cjelovita” te se može smatrati da u načelu ispunjava zahtjeve u pogledu podataka i informacija iz Priloga II. i III. Direktivi 91/414/EEZ.
The designated rapporteur Member State submitted a draft assessment report on 3 November 2009.
Imenovana država članica izvjestiteljica dostavila je 3. studenoga 2009. nacrt izvješća o ocjeni.
The draft assessment report was reviewed by the Member States and the European Food Safety Authority (hereinafter ‘the Authority’).
Nacrt izvješća o ocjeni pregledale su države članice i Europska agencija za sigurnost hrane (dalje u tekstu Agencija).
The Authority presented to the Commission its conclusion [4] on the pesticide risk assessment of the active substance Pseudomonas sp. strain DSMZ 13134 on 12 November 2012.
Agencija je 12. studenoga 2012. Komisiji dostavila svoj zaključak [4] o stručnom pregledu procjene rizika od pesticida za aktivnu tvar Pseudomonas sp. soj DSMZ 13134.
The draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 16 July 2013 in the format of the Commission review report for Pseudomonas sp. strain DSMZ 13134.
Taj su nacrt izvješća o procjeni i zaključak Agencije pregledale države članice i Komisija u okviru Stalnog odbora za prehrambeni lanac i zdravlje životinja te su njegovu konačnu inačicu dovršile 16. srpnja 2013. u obliku izvješća Komisije o ponovnoj ocjeni za Pseudomonas sp. soj DSMZ 13134.
It has appeared from the various examinations made that plant protection products containing Pseudomonas sp. strain DSMZ 13134 may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Razna su ispitivanja pokazala kako se od sredstava za zaštitu bilja koja sadržavaju Pseudomonas sp. soj DSMZ 13134 može očekivati da načelno udovoljavaju zahtjevima utvrđenima u članku 5. stavku 1. točkama (a) i (b) i članku 5. stavku 3. Direktive 91/414/EEZ, posebno u pogledu uporaba koje su ispitane i detaljno opisane u Izvješću Komisije o ponovnoj ocjeni.
It is therefore appropriate to approve Pseudomonas sp. strain DSMZ 13134.
Stoga je primjereno odobriti Pseudomonas sp. soj DSMZ 13134.
Without prejudice to the obligations provided for in Regulation (EC) No 1107/2009 as a consequence of approval, taking into account the specific situation created by the transition from Directive 91/414/EEC to Regulation (EC) No 1107/2009, the following should, however, apply.
Ne dovodeći u pitanje obveze predviđene u Uredbi (EZ) br. 1107/2009 koje proizlaze iz odobrenja i uzimajući u obzir posebnu situaciju nastalu prelaskom s Direktive 91/414/EEZ na Uredbu (EZ) br. 1107/2009, trebalo bi se međutim primjenjivati sljedeće.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing Pseudomonas sp. strain DSMZ 13134.
Državama članicama bi nakon odobrenja trebalo omogućiti šestomjesečno razdoblje za ponovnu ocjenu odobrenja za sredstva za zaštitu bilja koja sadržavaju Pseudomonas sp. soj DSMZ 13134.
The active substance Pseudomonas sp. strain DSMZ 13134, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna tvar Pseudomonas sp. soj DSMZ 13134, kako je navedena u Prilogu I., odobrava se podložno uvjetima utvrđenima u tom Prilogu.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing Pseudomonas sp. strain DSMZ 13134 as an active substance by 31 July 2014.
U skladu s Uredbom (EZ) br. 1107/2009 države članice prema potrebi do 31. srpnja 2014. moraju izmijeniti ili povući postojeća odobrenja za sredstva za zaštitu bilja koja sadržavaju Pseudomonas sp. soj DSMZ 13134 kao aktivnu tvar.
By that date they shall in particular verify that the conditions in Annex I to this Regulation are met, with the exception of those identified in the column on specific provisions of that Annex, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to Directive 91/414/EEC in accordance with the conditions of Article 13(1) to (4) of that Directive and Article 62 of Regulation (EC) No 1107/2009.
Do tog datuma posebno moraju provjeriti jesu li ispunjeni uvjeti iz Priloga I. ovoj Uredbi, uz iznimku onih utvrđenih u stupcu o posebnim odredbama tog Priloga, te posjeduje li nositelj odobrenja dokumentaciju odnosno ima li pristup dokumentaciji koja udovoljava zahtjevima iz Priloga II. Direktivi 91/414/EEZ u skladu s uvjetima članka 13. stavaka od 1. do 4. te Direktive i članka 62. Uredbe (EZ) br. 1107/2009.
By way of derogation from paragraph 1, for each authorised plant protection product containing Pseudomonas sp. strain DSMZ 13134 as either the only active substance or as one of several active substances, all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 31 January 2014 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account the column on specific provisions of Annex I to this Regulation.
Odstupajući od stavka 1., države članice najkasnije do 31. siječnja 2014. moraju ponovno ocijeniti svako odobreno sredstvo za zaštitu bilja koje sadržava Pseudomonas sp. soj DSMZ 13134 kao jedinu aktivnu tvar ili kao jednu od nekoliko aktivnih tvari koje su navedene u Prilogu Provedbenoj uredbi (EU) br. 540/2011, u skladu s jedinstvenim načelima iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009, na temelju dokumentacije koja udovoljava zahtjevima iz Priloga III. Direktivi 91/414/EEZ i uzimajući u obzir stupac s posebnim odredbama iz Priloga I. ovoj Uredbi.
in the case of a product containing Pseudomonas sp. strain DSMZ 13134 as the only active substance, where necessary, amend or withdraw the authorisation by 31 July 2015 at the latest; or
u slučaju da sredstvo sadržava Pseudomonas sp. soj DSMZ 13134 kao jedinu aktivnu tvar prema potrebi izmijeniti ili povući odobrenje najkasnije do 31. srpnja 2015.; ili
in the case of a product containing Pseudomonas sp. strain DSMZ 13134 as one of several active substances, where necessary, amend or withdraw the authorisation by 31 July 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or those substances, whichever is the latest.
u slučaju da sredstvo sadržava Pseudomonas sp. soj DSMZ 13134 kao jednu od nekoliko aktivnih tvari prema potrebi izmijeniti ili povući odobrenje do 31. srpnja 2015. ili do datuma utvrđenog za izmjenu ili povlačenje u odgovarajućem aktu ili aktima kojima su predmetna tvar ili tvari uvrštene u Prilog I. Direktivi 91/414/EEZ ili kojima su predmetna tvar ili tvari odobrene, ovisno o tome što je kasnije.
OJ L 193, 22.7.2008, p. 14.
SL L 193, 24.11.2009., str. 14.
Pseudomonas sp. strain DSMZ 13134
Pseudomonas sp. soj DSMZ 13134
Collection number: DSMZ 13134
Broj zbirke: DSMZ 13134
Minimum concentration: 3 × 1014 cfu/kg
Najmanja koncentracija: 3 × 1014 CFU/kg
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Pseudomonas sp. strain DSMZ 13134, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 16 July 2013 shall be taken into account.
Za provedbu jedinstvenih načela iz članka 29. stavka 6. Uredbe (EZ) br. 1107/2009 u obzir se moraju uzeti zaključci izvješća o ponovnoj ocjeni za Pseudomonas sp. soj DSMZ 13134, a posebno njegovi dodaci I. i II. u konačnoj inačici Stalnog odbora za prehrambeni lanac i zdravlje životinja od 16. srpnja 2013.
In this overall assessment Member States shall pay particular attention to the protection of operators and workers, taking into account that Pseudomonas sp. strain DSMZ 13134 is to be considered as a potential sensitizer.
U ovoj cjelokupnoj ocjeni države članice moraju obratiti posebnu pozornost na zaštitu primjenitelja i radnika, uzimajući u obzir da se smatra da Pseudomonas sp. soj DSMZ 13134 može uzrokovati preosjetljivost.
The applicant shall submit information to confirm the absence of an acute intratracheal and intraperitoneal toxicity/infectivity/pathogenicity potential.
Podnositelj zahtjeva mora dostaviti podatke u potvrdu nepostojanja akutnog intratrahealnog i intraperitonalnog potencijala toksičnosti/infektivnosti/patogenosti.
The applicant shall submit to the Commission, the Member States and the Authority that information by 31 January 2016.
Podnositelj zahtjeva te informacije mora dostaviti Komisiji, državama članicama i Agenciji do 31. siječnja 2016.
Minimum concentration: 3×1014 cfu/kg
Najmanja koncentracija: 3 × 1014 CFU/kg
The applicant shall submit to the Commission, the Member States and the Authority that information by 31 January 2016.’
Podnositelj zahtjeva te informacije dostavlja Komisiji, državama članicama i Agenciji do 31. siječnja 2016.”
For Pseudomonas sp. strain DSMZ 13134 the conditions of Article 80(1)(a) of Regulation (EC) No 1107/2009 are fulfilled by Commission Decision 2008/599/EC [3].
Odlukom Komisije 2008/599/EZ [3] potvrđeno je da Pseudomonas sp. soj DSMZ 13134 ispunjava uvjete iz članka 80. stavka 1. točke (a) Uredbe (EZ) br. 1107/2009.
Commission Implementing Regulation (EU) No 830/2013
Provedbena uredba Komisije (EU) br. 830/2013
Commission Implementing Regulation (EU) No 831/2013
Provedbena uredba Komisije (EU) br. 831/2013
amending for the 199th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the Al Qaida network
o 199. izmjeni Uredbe Vijeća (EZ) br. 881/2002 o određenim posebnim mjerama ograničavanja protiv određenih osoba i subjekata povezanih s mrežom Al Qaidom
On 19 August 2013 the Sanctions Committee of the United Nations Security Council (UNSC) decided to remove one natural person from its list of persons, groups and entities to whom the freezing of funds and economic resources should apply after considering a de-listing request submitted by this person and the Comprehensive Report of the Ombudsperson established pursuant to United Nations Security Council Resolution 1904(2009).
Odbor za sankcije Vijeća sigurnosti Ujedinjenih naroda (UNSC) odlučio je 19. kolovoza 2013. ukloniti s popisa osoba, skupina i subjekata na koje se odnosi zamrzavanje financijskih sredstava i gospodarskih izvora jednu fizičku osobu nakon razmatranja zahtjeva za uklanjanje s popisa koji je ta osoba predala te sveobuhvatnog izvješća Ombudsmana utvrđenog u skladu s Rezolucijom Vijeća sigurnosti Ujedinjenih naroda 1904 (2009.).
Furthermore, on 5 August 2013, the Sanctions Committee of the UNSC decided to amend three entries on the list.
Nadalje, 5. kolovoza 2013. Odbor za sankcije Vijeća sigurnosti Ujedinjenih naroda odlučio je izmijeniti tri unosa na popisu.
Annex I to Regulation (EC) No 881/2002 should therefore be updated accordingly,
Prilog I. Uredbi (EZ) br. 881/2002 treba stoga na odgovarajući način ažurirati,
The following entry under the heading ‘Natural persons’ is deleted:
Sljedeći se unosi pod naslovom „Fizičke osobe” brišu:
‘Mohammed Daki. Address: Casablanca, Morocco. Date of birth: 29.3.1965. Place of birth: Casablanca, Morocco. Nationality: Moroccan. Passport No: (a) G 482731 (Moroccan passport), (b) L446524 (Moroccan passport). National identification No: BE-400989 (Moroccan National Identity Card). Other information: (a) Father’s name is Lahcen; (b) Mother’s name is Izza Brahim; (c) Deported from Italy to Morocco on 10.12.2005. Date of designation referred to in Article 2a (4) (b): 12.11.2003.’
„Mohammed Daki. Adresa: Casablanca, Maroko. Datum rođenja: 29.3.1965. Mjesto rođenja: Casablanca, Maroko. Državljanstvo: marokansko. Broj putovnice: (a) G 482731 (marokanska putovnica), (b) L446524 (marokanska putovnica). Nacionalni identifikacijski broj: BE-400989 (marokanska nacionalna osobna iskaznica). Ostali podaci: (a) ime oca Lahcen; (b) ime majke Izza Brahim; (c) deportiran iz Italije u Maroko 10.12.2005. Datum određenja iz članka 2.a stavka 4. točke (b): 12.11.2003.”
The entry ‘Ata Abdoulaziz Rashid (alias (a) Ata Abdoul Aziz Barzingy, (b) Abdoulaziz Ata Rashid). Date of birth: 1.12.1973. Place of birth: Sulaimaniya, Iraq. Nationality: Iraqi. Passport No: German travel document (‘Reiseausweis’) A 0020375. Other information: (a) In prison in Germany; (b) Member of Ansar Al-Islam. Date of designation referred to in Article 2a (4) (b): 6.12.2005.’ under the heading ‘Natural persons’ shall be replaced by the following:
Unos „Ata Abdoulaziz Rashid (alias (a) Ata Abdoul Aziz Barzingy, (b) Abdoulaziz Ata Rashid). Datum rođenja: 1.12.1973. Mjesto rođenja: Sulaimaniya, Irak. Državljanstvo: iračko. Broj putovnice: njemačka putna isprava („Reiseausweis”) A 0020375. Ostali podaci: (a) u zatvoru u Njemačkoj; (b) član Ansar Al-Islama. Datum određenja iz članka 2.a stavka 4. točke (b): 6.12.2005.” pod naslovom „Fizičke osobe” zamjenjuje se sljedećim: